Cargando…
The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191361/ https://www.ncbi.nlm.nih.gov/pubmed/10310599 |
_version_ | 1782338646781722624 |
---|---|
author | Eggers, Paul W. Connerton, Rose McMullan, Michael |
author_facet | Eggers, Paul W. Connerton, Rose McMullan, Michael |
author_sort | Eggers, Paul W. |
collection | PubMed |
description | This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for black people is 2.8 times that of white people. Incidence is highest for persons 65 to 69 years of age. Total patient survival is 44 percent 5 years after renal failure onset. Total Medicare enrollment for ESRD quadrupled between the years 1974 and 1981. |
format | Online Article Text |
id | pubmed-4191361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1984 |
publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
record_format | MEDLINE/PubMed |
spelling | pubmed-41913612014-11-04 The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival Eggers, Paul W. Connerton, Rose McMullan, Michael Health Care Financ Rev Research Article This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for black people is 2.8 times that of white people. Incidence is highest for persons 65 to 69 years of age. Total patient survival is 44 percent 5 years after renal failure onset. Total Medicare enrollment for ESRD quadrupled between the years 1974 and 1981. CENTERS for MEDICARE & MEDICAID SERVICES 1984 /pmc/articles/PMC4191361/ /pubmed/10310599 Text en |
spellingShingle | Research Article Eggers, Paul W. Connerton, Rose McMullan, Michael The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title | The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title_full | The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title_fullStr | The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title_full_unstemmed | The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title_short | The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival |
title_sort | medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191361/ https://www.ncbi.nlm.nih.gov/pubmed/10310599 |
work_keys_str_mv | AT eggerspaulw themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival AT connertonrose themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival AT mcmullanmichael themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival AT eggerspaulw medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival AT connertonrose medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival AT mcmullanmichael medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival |